Tuesday, November 3, 2026
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
No Result
View All Result
Home Medical Marijuana

Study: Cannabis Associated with Reduced Opioid Use, Prolonged Benefits in Pain Patients

by NORML
June 19, 2020
in Medical Marijuana
0
Study: Medical Cannabis Access Associated with Fewer Workers’ Comp Claims
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

by NORML June 19, 2020

The daily use of cannabis by patients with chronic pain conditions is associated with prolonged improvements in pain management and subjects’ overall quality of life, as well as sustained reductions in the use of opioids, according to longitudinal data published in the journal Pain Medicine.

A team of Canadian researchers assessed the short-term and long-term impacts of medical cannabis treatment in 751 chronic pain subjects. Participants in the study consumed cannabis daily for a period of 12 months. Sixty percent of subjects reported having no previous experience with cannabis prior to their involvement in the study.

Investigators observed clinically significant improvements in patients’ pain severity “as early as one month after initiating treatment and [these improvements] were maintained over the course of the 12-month observation period.” In addition, patients’ “reported frequencies of fatigue, headaches, feelings of anxiety, and nausea decreased compared with baseline.”

Patients who were taking opioids prior to their enrollment in the study reduced their daily intake of opiates over the trial period — a finding that is consistent with those of several other longitudinal studies, such as those here, here, and here. Investigators observed initial reductions in patients’ opioid consumption at three months. Patients further reduced their opioid intake at six months and again at twelve months.

Authors concluded, “Taken together, the results of this study add to the cumulative evidence in support of plant-based MC (medical cannabis) as a safe and effective treatment option and potential opioid substitute or augmentation therapy for the management of chronic pain symptomatology and quality of life.”

Commenting on the study’s findings, NORML Deputy Director Paul Armentano said, “These outcomes add to the growing body of literature supportive of the therapeutic use of cannabis as an opioid-sparing analgesic agent.”

The abstract of the study, “Medical cannabis for the management of pain and quality of life in chronic pain patients: A prospective observational study,” appears in Pain Medicine. Additional information is available in the NORML fact-sheet, ‘Relationship Between Marijuana and Opioids.’

Views: 450
Previous Post

Drug Policy Alliance Statement on New Details in Rayshard Brooks Killing

Next Post

Study: Cannabis Associated with Reduced Opioid Use, Prolonged Benefits in Pain Patients

NORML

Related Posts

Maryland’s New Law Shields Veterinarians Recommending Medical Cannabis for Pets

Maryland’s New Law Shields Veterinarians Recommending Medical Cannabis for Pets

by Keegan MacDonald
October 4, 2026
0

Maryland Sets a New Standard for Veterinary Cannabis RecommendationsStarting this week, Maryland veterinarians who recommend medical marijuana for animals are...

USPS Allowed to Deliver Medical Marijuana Following Trump-Era Rescheduling, Georgia Officials Confirm

USPS Allowed to Deliver Medical Marijuana Following Trump-Era Rescheduling, Georgia Officials Confirm

by Keegan MacDonald
August 25, 2026
0

Can USPS Legally Deliver Medical Marijuana?Yes. Georgia state officials have confirmed that under a rescheduling move made during the Trump...

New Congressional Amendment Could Enable VA Medical Marijuana Recommendations for Veterans

New Congressional Amendment Could Enable VA Medical Marijuana Recommendations for Veterans

by Keegan MacDonald
May 11, 2026
0

Can Veterans Get Medical Marijuana Recommendations Through the VA?Recent legislative efforts suggest the answer could soon be yes. A new...

How many marijuana studies occurred in 2025?

How many marijuana studies occurred in 2025?

by Graham Cooper
December 11, 2025
0

A slightly misleading article was posted on NORML that states how many cannabis-related studies have been published in 2025 compared...

Next Post
Study: Cannabis Associated with Reduced Opioid Use, Prolonged Benefits in Pain Patients

Study: Cannabis Associated with Reduced Opioid Use, Prolonged Benefits in Pain Patients

Is a rise in heart attacks linked to cannabis legalization?

Is a rise in heart attacks linked to cannabis legalization?

October 30, 2026
Cannabis Policy Influences Voter Decisions: 78% of Consumers Say It’s a Dealbreaker

Cannabis Policy Influences Voter Decisions: 78% of Consumers Say It’s a Dealbreaker

October 28, 2026
Virginia Lawmaker Indicted in Federal Marijuana Trafficking Case: What It Means for Cannabis Policy

Virginia Lawmaker Indicted in Federal Marijuana Trafficking Case: What It Means for Cannabis Policy

October 28, 2026
ADVERTISEMENT
Sign up for the PP Newsletter

Categories

  • Age Restrictions
  • Air Travel
  • All Categories
  • American Culture
  • Animal Health
  • Anxiety
  • Anxiety Relief
  • Ballot Initiative
  • Bioplastics
  • Bipartisan Bill
  • Bipartisan Politics
  • Brain Science
  • Business
  • Canada
  • Cancer
  • Cancer Care
  • Cancer Treatment
  • Cannabinoid Receptors
  • Cannabinoids
  • cannabis
  • Cannabis Banking
  • Cannabis Brands
  • Cannabis Business
  • Cannabis Compliance
  • Cannabis Consumers
  • Cannabis Culture
  • Cannabis Extraction
  • Cannabis Finance
  • Cannabis Health Risks
  • Cannabis History
  • Cannabis Industry
  • Cannabis Legalization
  • Cannabis Legislation
  • Cannabis Market
  • Cannabis Mergers
  • Cannabis Policy
  • Cannabis Reform
  • Cannabis Regulation
  • Cannabis Research
  • Cannabis Tax
  • Cannabis Taxation
  • Cannabis Tourism
  • Cannabis Travel
  • Cannabis Trends
  • Cannabis Use Disorder
  • Cardiovascular Effects
  • CB1 Receptor
  • CB2 Receptor
  • CBD
  • China
  • Cigarette Smoking
  • College Tuition
  • Colorado
  • Congress
  • Congressional Amendment
  • Consumer Health
  • Controlled Substances Act
  • Criminal Justice
  • Criminal Justice Reform
  • Culture
  • DEA
  • Deceptive Marketing
  • Delaware
  • Democrats
  • Dispensary Closures
  • DMV Region
  • Donald Trump
  • Drug Policy
  • Drug Reform
  • Elections
  • Employment Law
  • Endocannabinoid System
  • Entourage Effect
  • Environment
  • Farm Bill
  • FBI Data
  • FDA
  • Featured
  • Federal Cannabis Law
  • Federal Cannabis Policy
  • Federal Indictment
  • Federal Law
  • Federal Lawsuit
  • Federal Regulation
  • Federally Funded Study
  • Financial Services
  • Foreign Investment
  • Georgia
  • Glioblastoma
  • GOP Senators
  • Green Thumb Industries
  • Gun Rights
  • Health Research
  • Health Studies
  • Heart Health
  • Hemp
  • Hemp Business
  • Hemp Cultivation
  • Hemp Market
  • Hemp Regulation
  • Hemp-Derived THC
  • Illegal Market
  • Industry Risks
  • Insomnia
  • Investors
  • Jeff Sessions
  • Job Loss
  • John Fetterman
  • John Hickenlooper
  • John James
  • Kratom
  • Law Enforcement
  • Lawmakers
  • Legal Cannabis Industry
  • Legal Compliance
  • Legal Precedent
  • Legalization
  • Legislation
  • Lifestyle
  • Lower Back Pain
  • Marijuana
  • Marijuana Arrests
  • Marijuana Business
  • Marijuana Clemency
  • Marijuana Descheduling
  • Marijuana Extracts
  • Marijuana IPOs
  • Marijuana Legalization
  • Marijuana Policy
  • Marijuana Reform
  • Marijuana Regulation
  • Marijuana Rescheduling
  • Marijuana Safety
  • Marijuana Tax
  • Marijuana Trafficking
  • Marijuana Use
  • Marijuana Users
  • Marijuana Withdrawal
  • Market Trends
  • Maryland
  • Massachusetts
  • Medical
  • Medical Cannabis
  • Medical Claims
  • Medical Marijuana
  • Medical Research
  • Mental Health
  • Michael Bennet
  • Michael Douglas
  • Michigan
  • Michigan Cannabis
  • Military Veterans
  • MJBizDaily
  • Mood Disorders
  • MSOs
  • Nasdaq
  • National Security
  • New Jersey
  • Nightmares
  • North Carolina
  • NYSE
  • Oklahoma
  • Older Adults
  • Opioid Reduction
  • Overdose Myths
  • Packaging
  • Pain Management
  • Patient Care
  • Pets
  • Police Search
  • Policy
  • Politics
  • Potent Cannabis
  • Pre-rolls
  • Product Safety
  • Psychedelics
  • PTSD
  • Public Education
  • Public Health
  • Public Listings
  • Public Safety
  • Rand Paul
  • Recreational Cannabis
  • Recreational Marijuana
  • Regulation
  • Regulatory Challenges
  • Regulatory Compliance
  • Research
  • Retail Cannabis
  • Retail Strategy
  • SAFE Banking Act
  • Second Amendment
  • Senior Marijuana Use
  • Sharon Stone
  • Sleep Disorders
  • Small Business
  • SNDL
  • Social Equity
  • State Budget
  • State Cannabis Officials
  • State Cannabis Policy
  • State Lawmakers
  • State Legalization
  • State Legislation
  • Substance Use
  • Supreme Court
  • Sustainability
  • Symptom Management
  • Tax Dispute
  • Terpenes
  • Testosterone
  • THC
  • THC Potency
  • THC Products
  • Trump Administration
  • TSA
  • U.S. Cannabis Industry
  • U.S. Hemp Industry
  • U.S. Senate
  • uncategorized
  • Underage Cannabis Use
  • Uplisting
  • US Cannabis
  • US Cannabis Market
  • US Politics
  • US Study
  • USPS
  • Veterans
  • Veterans Affairs
  • Veterinarians
  • Veterinary Medicine
  • Virginia
  • Voting Behavior
  • World Cup 2024
  • Young Men

Recent Posts

  • Is a rise in heart attacks linked to cannabis legalization?
  • Cannabis Policy Influences Voter Decisions: 78% of Consumers Say It’s a Dealbreaker

Browse by Tag

420 cannabis Edibles Legalization marijuana NORML THC

AFFILIATES

© Pot Portal. All rights reserved.

No Result
View All Result

© Pot Portal. All rights reserved.